Head-to-head comparisons of medication uses, side effects, warnings, and more.
Dupixent (dupilumab)
Fasenra (benralizumab)
Dupixent (dupilumab)
Fasenra (benralizumab)
Summary of Dupixent vs. Fasenra
Summary for Interleukin antagonist
Prescription only
Dupixent (dupilumab) is an injection that helps treat certain inflammatory conditions. This includes eczema, asthma, and chronic obstructive pulmonary disease (COPD), among others. It's a biologic medication known as an interleukin antagonist that lowers inflammation. Dupixent (dupilumab) comes as prefilled pens and prefilled syringes. It's injected under the skin of the belly or thighs (or in the back of the upper arm with someone's help). The dosing schedule depends on the condition you have, your age, and your weight. It's injected either every week, every 2 weeks, or every 4 weeks. Side effects include injection site reactions and eye problems.
Summary for Interleukin antagonist
Prescription only
Fasenra (benralizumab) is an injectable biologic medication that's used to treat severe eosinophilic asthma in people 6 years and older. It belongs to a class of medications called interleukin antagonists. Fasenra (benralizumab) is available as a pen that you can inject at home, either by yourself or with the help of a caregiver. The usual dosing is to inject under the skin every month for the first 3 months, and then every 2 months after that. Common side effects include headache and sore throat.
Indications of Dupixent vs. Fasenra
Indications for
•Moderate-to-severe eczema - for people 6 months and older
•Moderate-to-severe asthma - add-on maintenance for people 6 years and older